Offering Quality iPSC-derived Cell Products for Disease Modeling, Drug Discovery, and Drug Safety Screening

 Human iPSC-derived cells are rapidly becoming a vital tool in the drug development industry for the discovery, preclinical efficacy testing, and safety profiling of new medicines.

 Celogics is committed to developing and producing highly reproducible iPSCs that help cutting-edge researchers and pharmaceutical companies accelerate the discovery and development of next-generation therapies.


Quality Support

for Quality Research

With our specific guide, the Celo.Cardiomyocytes will show at the appropriate densities to create synchronous layers of cardiomyocytes appropriate for a variety of applications related to electrophysiological behavior assays.

We provide as much as information researchers commonly need to utilize our cells in your research. Visit our Product Literature page and FAQs to find answers to your questions.

Do not find yours? We are open to suggestions and feedbacks!



Celo.cardiomyocytes should be handled by technically qualified individuals complying with good laboratory practices, applicable laboratory regulations and the MSDS. Following the User Guide herein is recommended for best results.


Celo.cardiomyocytes are intended for research use only, not intended for any type of use in animals or humans.